Newsletter
PharmStars: A New Approach to Accelerating Digital Health-Pharma Partnership with Naomi Fried and Laura Gunn of Pharmstars

Outcomes Rocket

PharmStars: A New Approach to Accelerating Digital Health-Pharma Partnership with Naomi Fried and Laura Gunn of Pharmstars

September 16, 2021

PharmStars: A New Approach to Accelerating Digital Health-Pharma Partnership with Naomi Fried and Laura Gunn of Pharmstars

In this Pharma Outcomes Rocket episode, we are privileged to have two special guests. Naomi Fried is the founder and CEO of Pharmstars and Laura Gunn is the Managing Director of Pharmstars,  the first pharma-focused accelerator for digital health startups.

Naomi and Laura discuss how Pharmstars address the gap between pharma manufacturers and startups. They share how the accelerator educates and mentors startups, how it facilitates and accelerates successful partnerships, how it reduces the gap between pharma and digital health startups, and more. They also talk of the Pharmstars leverage as the only accelerator in the space with a comprehensive curriculum that’s built and tailored for digital health startups that want to work with pharma.

If you are a startup looking to learn more about pharma or a pharma manufacturer looking to improve your digital health innovations, this interview is for you. Please tune in!

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

Subscribe to Health Podcast Network

Proudly supported by:

cover
COVID, AI, and the Future of Medicine with Eric Topol Exploring lingering questions about COVID-19 with Eric Topol, the Founder and Director of the Scripps Research Translational Institute.